AAPL   322.47 (+1.37%)
MSFT   183.49 (+0.92%)
FB   229.30 (+0.07%)
GOOGL   1,433.10 (+0.90%)
AMZN   2,424.56 (+0.59%)
NVDA   345.68 (+1.37%)
BABA   202.17 (+0.49%)
MU   47.59 (-3.76%)
GE   6.88 (-5.62%)
TSLA   817.49 (-0.33%)
T   31.43 (-1.35%)
ACB   15.71 (+2.68%)
GILD   75.65 (+1.00%)
NFLX   418.34 (-0.37%)
BAC   25.24 (-2.85%)
BA   151.83 (+1.54%)
AAPL   322.47 (+1.37%)
MSFT   183.49 (+0.92%)
FB   229.30 (+0.07%)
GOOGL   1,433.10 (+0.90%)
AMZN   2,424.56 (+0.59%)
NVDA   345.68 (+1.37%)
BABA   202.17 (+0.49%)
MU   47.59 (-3.76%)
GE   6.88 (-5.62%)
TSLA   817.49 (-0.33%)
T   31.43 (-1.35%)
ACB   15.71 (+2.68%)
GILD   75.65 (+1.00%)
NFLX   418.34 (-0.37%)
BAC   25.24 (-2.85%)
BA   151.83 (+1.54%)
AAPL   322.47 (+1.37%)
MSFT   183.49 (+0.92%)
FB   229.30 (+0.07%)
GOOGL   1,433.10 (+0.90%)
AMZN   2,424.56 (+0.59%)
NVDA   345.68 (+1.37%)
BABA   202.17 (+0.49%)
MU   47.59 (-3.76%)
GE   6.88 (-5.62%)
TSLA   817.49 (-0.33%)
T   31.43 (-1.35%)
ACB   15.71 (+2.68%)
GILD   75.65 (+1.00%)
NFLX   418.34 (-0.37%)
BAC   25.24 (-2.85%)
BA   151.83 (+1.54%)
AAPL   322.47 (+1.37%)
MSFT   183.49 (+0.92%)
FB   229.30 (+0.07%)
GOOGL   1,433.10 (+0.90%)
AMZN   2,424.56 (+0.59%)
NVDA   345.68 (+1.37%)
BABA   202.17 (+0.49%)
MU   47.59 (-3.76%)
GE   6.88 (-5.62%)
TSLA   817.49 (-0.33%)
T   31.43 (-1.35%)
ACB   15.71 (+2.68%)
GILD   75.65 (+1.00%)
NFLX   418.34 (-0.37%)
BAC   25.24 (-2.85%)
BA   151.83 (+1.54%)
Log in

NASDAQ:PIRSPieris Pharmaceuticals News Headlines

$3.31
-0.09 (-2.65 %)
(As of 05/28/2020 02:41 PM ET)
Add
Compare
Today's Range
$3.24
Now: $3.31
$3.53
50-Day Range
$2.34
MA: $2.74
$3.30
52-Week Range
$1.60
Now: $3.31
$6.04
Volume42,339 shs
Average Volume328,829 shs
Market Capitalization$173.18 million
P/E RatioN/A
Dividend YieldN/A
Beta1.43

Headlines

Pieris Pharmaceuticals (NASDAQ PIRS) News Headlines

Source:
DateHeadline
Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare ConferencePieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare Conference
www.finanznachrichten.de - May 28 at 11:26 AM
Pieris Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare ConferencePieris Pharmaceuticals to Present at the Jefferies 2020 Virtual Healthcare Conference
finance.yahoo.com - May 28 at 11:26 AM
Zacks: Analysts Anticipate Pieris Pharmaceuticals Inc (NASDAQ:PIRS) Will Announce Quarterly Sales of $9.07 MillionZacks: Analysts Anticipate Pieris Pharmaceuticals Inc (NASDAQ:PIRS) Will Announce Quarterly Sales of $9.07 Million
www.americanbankingnews.com - May 15 at 3:28 AM
Earnings Update: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Just Reported And Analysts Are Boosting Their EstimatesEarnings Update: Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Just Reported And Analysts Are Boosting Their Estimates
finance.yahoo.com - May 14 at 1:48 PM
Q2 2020 EPS Estimates for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) Raised by AnalystQ2 2020 EPS Estimates for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) Raised by Analyst
www.americanbankingnews.com - May 14 at 8:49 AM
Pieris Pharmaceuticals Inc Forecasted to Earn Q2 2020 Earnings of ($0.18) Per Share (NASDAQ:PIRS)Pieris Pharmaceuticals Inc Forecasted to Earn Q2 2020 Earnings of ($0.18) Per Share (NASDAQ:PIRS)
www.americanbankingnews.com - May 14 at 8:49 AM
-$0.17 EPS Expected for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) This Quarter-$0.17 EPS Expected for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) This Quarter
www.americanbankingnews.com - May 13 at 4:50 PM
Pieris Pharmaceuticals (NASDAQ:PIRS) Posts Quarterly  Earnings Results, Beats Estimates By $0.10 EPSPieris Pharmaceuticals (NASDAQ:PIRS) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS
www.americanbankingnews.com - May 12 at 11:26 PM
Edited Transcript of PIRS earnings conference call or presentation 11-May-20 12:00pm GMTEdited Transcript of PIRS earnings conference call or presentation 11-May-20 12:00pm GMT
finance.yahoo.com - May 12 at 4:47 AM
Pieris Pharmaceuticals (PIRS) CEO Steve Yoder on Q1 2020 Results - Earnings Call TranscriptPieris Pharmaceuticals' (PIRS) CEO Steve Yoder on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 6:46 PM
Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate UpdatePieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
www.finanznachrichten.de - May 11 at 1:46 PM
Pieris Pharmaceuticals EPS beats by $0.08, beats on revenuePieris Pharmaceuticals EPS beats by $0.08, beats on revenue
seekingalpha.com - May 11 at 1:46 PM
Pieris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate UpdatePieris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - May 11 at 1:46 PM
Pieris Pharmaceuticals: Q1 Earnings InsightsPieris Pharmaceuticals: Q1 Earnings Insights
finance.yahoo.com - May 11 at 1:46 PM
Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Tops Revenue EstimatesPieris Pharmaceuticals (PIRS) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 11 at 1:46 PM
Pieris Pharmaceuticals (PIRS) Set to Announce Earnings on MondayPieris Pharmaceuticals (PIRS) Set to Announce Earnings on Monday
www.americanbankingnews.com - May 5 at 8:36 PM
Pieris Pharmaceuticals to Host First Quarter 2020 Investor Call and Corporate Update on May 11, 2020Pieris Pharmaceuticals to Host First Quarter 2020 Investor Call and Corporate Update on May 11, 2020
finance.yahoo.com - May 4 at 4:02 PM
Pieris Pharmaceuticals (PIRS) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleasePieris Pharmaceuticals (PIRS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - May 1 at 7:03 PM
Here's Why We're Watching Pieris Pharmaceuticals's (NASDAQ:PIRS) Cash Burn SituationHere's Why We're Watching Pieris Pharmaceuticals's (NASDAQ:PIRS) Cash Burn Situation
finance.yahoo.com - April 28 at 1:10 PM
Pieris Pharmaceuticals and AstraZeneca Present Single- Ascending Dose Phase 1a Data for Inhaled IL-4Rα AntagonistPieris Pharmaceuticals and AstraZeneca Present Single- Ascending Dose Phase 1a Data for Inhaled IL-4Rα Antagonist
www.bloomberg.com - April 27 at 12:09 AM
Pieris Pharmaceuticals, Inc. Common Stock (PIRS) Institutional HoldingsPieris Pharmaceuticals, Inc. Common Stock (PIRS) Institutional Holdings
www.nasdaq.com - April 22 at 7:42 PM
Biotech stocks have held up better than the broader market — and these five are potential winnersBiotech stocks have held up better than the broader market — and these five are potential winners
finance.yahoo.com - March 24 at 11:26 AM
Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Provides Update on Servier CollaborationPieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Provides Update on Servier Collaboration
www.finanznachrichten.de - March 23 at 6:07 PM
Pieris Pharmaceuticals Provides Update on Servier CollaborationPieris Pharmaceuticals Provides Update on Servier Collaboration
finance.yahoo.com - March 23 at 6:07 PM
Pieris Pharmaceuticals, Inc. Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesPieris Pharmaceuticals, Inc. Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
finance.yahoo.com - March 14 at 1:18 PM
Edited Transcript of PIRS earnings conference call or presentation 12-Mar-20 12:00pm GMTEdited Transcript of PIRS earnings conference call or presentation 12-Mar-20 12:00pm GMT
finance.yahoo.com - March 13 at 1:28 AM
Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Reports Full-Year 2019 Financial Results And Provides Corporate UpdatePieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Reports Full-Year 2019 Financial Results And Provides Corporate Update
www.finanznachrichten.de - March 12 at 7:51 AM
Pieris Pharmaceuticals EPS beats by $0.20, beats on revenuePieris Pharmaceuticals EPS beats by $0.20, beats on revenue
seekingalpha.com - March 12 at 7:51 AM
Pieris Pharmaceuticals Reports Full-Year 2019 Financial Results And Provides Corporate UpdatePieris Pharmaceuticals Reports Full-Year 2019 Financial Results And Provides Corporate Update
finance.yahoo.com - March 12 at 7:51 AM
Earnings Preview: Pieris Pharmaceuticals (PIRS) Q4 Earnings Expected to DeclineEarnings Preview: Pieris Pharmaceuticals (PIRS) Q4 Earnings Expected to Decline
finance.yahoo.com - March 9 at 1:42 PM
Pieris Pharmaceuticals to Host Full-Year 2019 Investor Call and Corporate Update on March 12, 2020Pieris Pharmaceuticals to Host Full-Year 2019 Investor Call and Corporate Update on March 12, 2020
finance.yahoo.com - March 5 at 10:27 AM
Pieris Pharmaceuticals Announces Presentation of Clinical Data for Anemia Drug Candidate, PRS-080, at the 54th ERA-EDTAPieris Pharmaceuticals Announces Presentation of Clinical Data for Anemia Drug Candidate, PRS-080, at the 54th ERA-EDTA
www.bloomberg.com - February 27 at 2:51 PM
Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals to Participate in Upcoming Scientific and Investor ConferencesPieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals to Participate in Upcoming Scientific and Investor Conferences
www.finanznachrichten.de - February 25 at 2:32 PM
Pieris Pharmaceuticals to Participate in Upcoming Scientific and Investor ConferencesPieris Pharmaceuticals to Participate in Upcoming Scientific and Investor Conferences
finance.yahoo.com - February 25 at 9:32 AM
Pieris Pharmaceuticals, Inc. Common Stock (PIRS) Revenue EPSPieris Pharmaceuticals, Inc. Common Stock (PIRS) Revenue EPS
www.nasdaq.com - February 23 at 10:58 PM
Pieris Pharma down 9% on Aska Pharma exit from PRS-080 developmentPieris Pharma down 9% on Aska Pharma exit from PRS-080 development
seekingalpha.com - January 27 at 8:47 PM
The Pieris Pharmaceuticals (NASDAQ:PIRS) Share Price Is Up 95% And Shareholders Are Holding OnThe Pieris Pharmaceuticals (NASDAQ:PIRS) Share Price Is Up 95% And Shareholders Are Holding On
finance.yahoo.com - January 20 at 1:53 PM
Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Leadership UpdatePieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Leadership Update
www.finanznachrichten.de - January 9 at 3:51 AM
Pieris Pharmaceuticals Announces Leadership UpdatePieris Pharmaceuticals Announces Leadership Update
finance.yahoo.com - January 8 at 4:44 PM
Pieris Pharmaceuticals Presents Data Demonstrating Monotherapy Clinical Benefit with 4-1BB/HER2 Bispecific PRS-343 inPieris Pharmaceuticals Presents Data Demonstrating Monotherapy Clinical Benefit with 4-1BB/HER2 Bispecific PRS-343 in
www.bloomberg.com - December 27 at 11:09 PM
Here is What Hedge Funds Think About Pieris Pharmaceuticals, Inc. (PIRS)Here is What Hedge Funds Think About Pieris Pharmaceuticals, Inc. (PIRS)
finance.yahoo.com - December 19 at 10:58 PM
Gene Therapy the Next Best Thing: Here's WhyGene Therapy the Next Best Thing: Here's Why
finance.yahoo.com - December 4 at 12:39 PM
Does Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) CEO Pay Matter?Does Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) CEO Pay Matter?
finance.yahoo.com - November 19 at 1:21 PM
Edited Transcript of PIRS earnings conference call or presentation 11-Nov-19 1:00pm GMTEdited Transcript of PIRS earnings conference call or presentation 11-Nov-19 1:00pm GMT
finance.yahoo.com - November 18 at 5:19 PM
Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Asthma-focused Translational Research Collaboration with the University of PittsburghPieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Asthma-focused Translational Research Collaboration with the University of Pittsburgh
www.finanznachrichten.de - November 15 at 8:35 AM
Pieris Pharmaceuticals Announces Asthma-focused Translational Research Collaboration with the University of PittsburghPieris Pharmaceuticals Announces Asthma-focused Translational Research Collaboration with the University of Pittsburgh
finance.yahoo.com - November 15 at 8:35 AM
Pieris Pharmaceuticals, Inc. (PIRS) CEO Stephen Yoder on Q3 2019 Results - Earnings Call TranscriptPieris Pharmaceuticals, Inc. (PIRS) CEO Stephen Yoder on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 6:54 PM
Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate UpdatePieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
www.finanznachrichten.de - November 11 at 8:51 AM
Pieris Pharmaceuticals EPS beats by $0.18, beats on revenuePieris Pharmaceuticals EPS beats by $0.18, beats on revenue
seekingalpha.com - November 11 at 8:51 AM
Pieris Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate UpdatePieris Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 11 at 8:51 AM
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.